Hepcortespenlisimut-L

hepcortespenlisimut-L · Immunitor LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hepcortespenlisimut-L, covering 2019-02-26 to 2019-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Liver Cancer Immunotherapy: Placebo-controlled Clinical Trial of Hepcortespenlisimut-L [Phase 3]